MedTrace Logo

Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia

NCT01791543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2023-02-01

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to assess the effectiveness and safety of a new device called an Intramural Needle Ablation Catheter (INA catheter). The INA catheter is used for locating and ablating ventricular arrhythmias that have failed standard radiofrequency ablation. This approach is desirable because some people have ventricular arrhythmias that originate deep within the heart muscle where it is not abolished by ablation with standard catheters.

The investigators seek to determine whether the INA catheter can potentially help people who have ventricular arrhythmias that have failed standard radiofrequency ablation. The investigators also want to determine if it is likely to be safe, without excessive side effects.

Conditions

  • Ventricular Tachycardia

Interventions

DEVICE

Intramural Needle Ablation Catheter

Sponsors & Collaborators

  • William Stevenson

    lead OTHER

Principal Investigators

  • William G. Stevenson, M.D. · Vanderbilt Heart and Vascular Institute

  • Usha Tedrow, M.D. · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2022-05-27
Completion
2022-05-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01791543 on ClinicalTrials.gov